S IgM nephropathy-successful treatment with rituximab
Joint Authors
Ahmad, Fahim al-Din Azhar
al-Manawi, Ashraf
Source
Saudi Journal of Kidney Diseases and Transplantation
Issue
Vol. 30, Issue 1 (28 Feb. 2019), pp.235-238, 4 p.
Publisher
Saudi Center for Organ Transplantation
Publication Date
2019-02-28
Country of Publication
Saudi Arabia
No. of Pages
4
Main Subjects
Topics
Abstract EN
Immunoglobulin M nephropathy (IgMN) is a primary glomerulonephritis which is characterized by variable degrees of morphological features ranging from minimal glomerular involvement to segmental or global sclerosis.
No specific treatment is known to date for this disease because of uncertainties in etiopathogenesis.
The mainstay treatment for this disease has been corticosteroids, which has varying degrees of resistance ranging from 0% to 50%.
We present the case of a 59-year-old Caucasian male who was referred to the outpatient nephrology clinic for the evaluation of proteinuria and was diagnosed with IgMN.
We successfully treated the patient with rituximab with resolution of his proteinuria
American Psychological Association (APA)
Ahmad, Fahim al-Din Azhar& al-Manawi, Ashraf. 2019. S IgM nephropathy-successful treatment with rituximab. Saudi Journal of Kidney Diseases and Transplantation،Vol. 30, no. 1, pp.235-238.
https://search.emarefa.net/detail/BIM-887135
Modern Language Association (MLA)
Ahmad, Fahim al-Din Azhar& al-Manawi, Ashraf. S IgM nephropathy-successful treatment with rituximab. Saudi Journal of Kidney Diseases and Transplantation Vol. 30, no. 1 (Jan. / Feb. 2019), pp.235-238.
https://search.emarefa.net/detail/BIM-887135
American Medical Association (AMA)
Ahmad, Fahim al-Din Azhar& al-Manawi, Ashraf. S IgM nephropathy-successful treatment with rituximab. Saudi Journal of Kidney Diseases and Transplantation. 2019. Vol. 30, no. 1, pp.235-238.
https://search.emarefa.net/detail/BIM-887135
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 238
Record ID
BIM-887135
